HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Satoru Muto Selected Research
Satoru Muto Research Topics
Disease
24
Neoplasms (Cancer)
03/2022 - 06/2003
22
Prostatic Neoplasms (Prostate Cancer)
04/2022 - 02/2005
13
Autosomal Dominant Polycystic Kidney (ADPKD)
11/2021 - 07/2002
10
Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 06/2003
3
Circulating Neoplastic Cells
01/2020 - 09/2014
3
Ataxia Telangiectasia (Louis Bar Syndrome)
09/2012 - 03/2008
2
Hypogonadism (Hypergonadotropic Hypogonadism)
07/2022 - 06/2008
2
Carcinoma (Carcinomatosis)
03/2022 - 07/2008
2
Non-Muscle Invasive Bladder Neoplasms
05/2021 - 03/2013
2
Adenocarcinoma
07/2020 - 04/2018
2
Cysts
04/2020 - 10/2015
2
Carcinogenesis
03/2020 - 10/2007
2
Drug-Related Side Effects and Adverse Reactions
01/2017 - 03/2013
2
Adenoma (Adenomas)
06/2016 - 06/2012
2
Erectile Dysfunction
01/2016 - 06/2008
2
Neoplasm Metastasis (Metastasis)
05/2015 - 01/2013
1
Dysbiosis
04/2022
1
Neurogenic Urinary Bladder (Bladder, Neurogenic)
03/2022
1
Diabetes Mellitus
01/2022
1
Hydronephrosis
01/2022
1
Hernia (Hernias)
07/2020
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1
Urinary Incontinence
06/2019
1
Chronic Renal Insufficiency
03/2017
1
Acute Kidney Injury (Acute Renal Failure)
03/2017
1
Disease Progression
12/2015
1
Hemolytic Anemia
07/2015
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
07/2015
1
Thrombocytopenia (Thrombopenia)
07/2015
1
Margins of Excision
05/2015
1
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2015
1
Testicular Neoplasms (Testicular Cancer)
01/2013
1
Teratoma (Teratoid Tumor)
01/2013
Drug/Important Bio-Agent (IBA)
9
Tolvaptan
FDA Link
11/2021 - 10/2015
7
Testosterone (Sustanon)
FDA Link
04/2022 - 06/2008
7
Biomarkers (Surrogate Marker)
IBA
03/2017 - 06/2008
6
Prostate-Specific Antigen (Semenogelase)
IBA
07/2020 - 07/2010
5
TEMPO
IBA
09/2021 - 10/2015
4
Proteins (Proteins, Gene)
FDA Link
04/2018 - 03/2008
4
Pharmaceutical Preparations
IBA
03/2017 - 06/2003
4
Phosphotransferases (Kinase)
IBA
09/2012 - 03/2008
3
Androgens
IBA
04/2022 - 09/2014
3
Curcumin
IBA
04/2018 - 07/2010
3
Histones (Histone)
IBA
09/2012 - 03/2008
3
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2007 - 06/2003
2
Acids
IBA
07/2022 - 09/2008
2
Vasopressins (Vasopressin)
IBA
11/2021 - 12/2015
2
Antigens
IBA
01/2020 - 10/2014
2
Platinum
IBA
01/2017 - 05/2015
2
Protons (Proton)
IBA
08/2014 - 05/2008
2
Isoflavones
IBA
02/2011 - 07/2010
1
Lactic Acid (Lactate)
FDA Link
Generic
04/2022
1
Indicators and Reagents (Reagents)
IBA
04/2022
1
pembrolizumab
IBA
03/2022
1
Serum Albumin
IBA
04/2020
1
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
03/2020
1
K 130
IBA
01/2020
1
Dihydrotestosterone (Androstanolone)
IBA
04/2018
1
Therapeutic Uses
IBA
04/2018
1
Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)
IBA
04/2018
1
3 beta-hydroxysteroid dehydrogenase type II
IBA
04/2018
1
Creatinine
IBA
03/2017
1
Cell-Free Nucleic Acids
IBA
01/2016
1
MicroRNAs (MicroRNA)
IBA
01/2016
1
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
01/2016
1
Arginine Vasopressin (Argipressin)
IBA
12/2015
1
Adenosine Monophosphate (AMP)
IBA
12/2015
1
Vasopressin Receptors (Arginine Vasopressin Receptor)
IBA
10/2015
1
Macrophage Colony-Stimulating Factor
IBA
10/2015
1
Autoantibodies
IBA
07/2015
1
Gemcitabine
FDA Link
05/2015
1
8-Hydroxy-2'-Deoxyguanosine
IBA
03/2015
1
pigment epithelium-derived factor
IBA
03/2015
1
Zoledronic Acid (Zometa)
FDA Link
09/2014
1
Luteinizing Hormone (Lutropin)
FDA Link
Generic
01/2013
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2013
Therapy/Procedure
15
Therapeutics
04/2022 - 07/2003
6
Prostatectomy (Retropubic Prostatectomy)
03/2022 - 05/2008
5
Cystectomy
03/2022 - 02/2008
5
Drug Therapy (Chemotherapy)
02/2018 - 08/2010
3
Castration
01/2020 - 09/2014
2
Urinary Diversion (Ileal Conduit)
03/2022 - 12/2021
2
Robotic Surgical Procedures
07/2020 - 05/2015
2
Solid-State Lasers
06/2016 - 01/2015
1
Ambulatory Care (Outpatient Care)
03/2022
1
Combined Modality Therapy
03/2022
1
Neoadjuvant Therapy
01/2022
1
Length of Stay
01/2022
1
Cardiopulmonary Resuscitation (CPR)
04/2020
1
Oral Administration
04/2018
1
Minimally Invasive Surgical Procedures
01/2017
1
Adjuvant Chemotherapy
01/2017
1
Physical Therapy Modalities (Physical Therapy Technique)
01/2016
1
Extracorporeal Shockwave Therapy
01/2016
1
Nephroureterectomy
07/2015
1
Nephrectomy
05/2015
1
Palliative Care (Palliative Therapy)
05/2015
1
Laser Therapy (Surgery, Laser)
01/2015
1
Intravesical Administration
03/2013
1
Orchiectomy (Orchidectomy)
01/2013